United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - mitomycin (unii: 50sg953sk6) (mitomycin - unii:50sg953sk6) - mitomycin for injection is not recommended as single-agent, primary therapy. it has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed. mitomycin is not recommended to replace appropriate surgery and/or radiotherapy. mitomycin is contraindicated in patients who have demonstrated a hypersensitive or idiosyncratic reaction to it in the past. mitomycin is contraindicated in patients with thrombocytopenia, coagulation disorder, or an increase in bleeding tendency due to other causes.

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - mitomycin (unii: 50sg953sk6) (mitomycin - unii:50sg953sk6) - mitomycin for injection, usp is not recommended as single-agent, primary therapy. it has been shown to be useful in the therapy of disseminated adenocarcinoma of the stomach or pancreas in proven combinations with other approved chemotherapeutic agents and as palliative treatment when other modalities have failed. mitomycin is not recommended to replace appropriate surgery and/or radiotherapy. mitomycin is contraindicated in patients who have demonstrated a hypersensitive or idiosyncratic reaction to it in the past. mitomycin is contraindicated in patients with thrombocytopenia, coagulation disorder, or an increase in bleeding tendency due to other causes.

Ireland - English - HPRA (Health Products Regulatory Authority)

kyowa kirin limited - mitomycin - powder for solution for injection - 10 milligram(s) - other cytotoxic antibiotics; mitomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

kyowa kirin limited - mitomycin - powder for solution for injection - 40 milligram(s) - other cytotoxic antibiotics; mitomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

kyowa kirin holdings b.v. - mitomycin - powder for solution for injection - 10 milligram(s) - other cytotoxic antibiotics; mitomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

kyowa kirin holdings b.v. - mitomycin - powder for solution for infusion - 40 milligram(s) - other cytotoxic antibiotics; mitomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

medac gesellschaft fur klinische spezialpraparate mbh - mitomycin - pdr+solv/soln/intravesical use - 20 milligram(s) - other cytotoxic antibiotics; mitomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

medac gesellschaft für klinische spezialpräparate mbh - mitomycin - powder and solvent for intravesical solution - 40 milligram(s) - other cytotoxic antibiotics; mitomycin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - mitomycin 20 mg - powder for solution for injection/infusion; powder for intravesical solution - 20 mg - mitomycin 20 mg - mitomycin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - mitomycin 2 mg - powder for solution for injection/infusion; powder for intravesical solution - 2 mg - mitomycin 2 mg - mitomycin